Monthly Archives: June 2018

Apogee Enterprises, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / June 28, 2018 / Apogee Enterprises, Inc. (NASDAQ: APOG) will be discussing their earnings results in their Q1 Earnings Call to be held on June 28, 2018 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://investornetwork.com/company/23418

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 503643

Canadian Exchanges Stock Scanner Baytex Energy, Encana, Whitecap Resources, and Canadian Natural Resources

LONDON, UK / ACCESSWIRE / June 28, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equitiesfrom the Oil & Gas – E&P industry: Baytex Energy, Encana, Whitecap Resources, and Canadian Natural Resources. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index lost 48.84 points, or 0.30%, to close Wednesday’s trading session at 16,231.25. The TSX Venture Exchange shaved off 8.19 points, or 1.10%, to finish at 736.90.

Moreover, the Energy index was up by 1.53%, closing at 205.48.

Today’s stocks of interest consist of: Baytex Energy Corporation (TSX: BTE), Encana Corporation (TSX: ECA), Whitecap Resources Inc. (TSX: WCP), and Canadian Natural Resources Ltd (TSX: CNQ). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Baytex Energy Corp.

Calgary, Canada headquartered Baytex Energy Corp.’s stock finished Wednesday’s session 1.60% higher at $4.45 with a total volume of 11.26 million shares traded. Over the last three months and the previous year, Baytex Energy’s shares have surged 23.61% and 39.94%, respectively. The Company’s shares are trading above its 200-day moving average. Baytex Energy’s 50-day moving average of $5.36 is above its 200-day moving average of $4.31. Shares of the Company, which engages in the acquisition, development, and production of oil and natural gas in the Western Canadian Sedimentary Basin and in the Eagle Ford in the US, are trading at a PE ratio of 87.25. View the research report on BTE.TO at:

www.active-investors.com/registration-sg/?symbol=BTE

Encana Corp.

On Wednesday, shares in Calgary, Canada headquartered Encana Corp. recorded a trading volume of 4.33 million shares, which was higher than their three months average volume of 3.97 million shares. The stock ended the day 4.88% higher at $17.83. Encana’s stock has gained 8.79% in the last month and 24.42% in the previous three months. Furthermore, the stock has surged 59.77% in the past year. The Company’s shares are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $16.61 is above its 200-day moving average of $15.56. Shares of Encana, which together with its subsidiaries, engages in the exploration, development, production, and marketing of natural gas, oil, and natural gas liquids, are trading at a PE ratio of 31.73. Get the free report on ECA.TO at:

www.active-investors.com/registration-sg/?symbol=ECA

Whitecap Resources Inc.

Calgary, Canada headquartered Whitecap Resources Inc.’s stock closed the day 3.54% higher at $9.06. The stock recorded a trading volume of 2.13 million shares, which was above its three months average volume of 2.02 million shares. Whitecap Resources’ shares have gained 12.83% in the last three months. Shares of the Company, which acquires and develops petroleum and natural gas properties in the Western Canada Sedimentary Basin, are trading above their 50-day and 200-day moving averages. Furthermore, the stock’s 50-day moving average of $9.04 is greater than its 200-day moving average of $8.72. Access the most recent report coverage on WCP.TO at:

www.active-investors.com/registration-sg/?symbol=WCP

Canadian Natural Resources Ltd

On Wednesday, shares in Calgary, Canada headquartered Canadian Natural Resources Ltd ended the session 1.68% higher at $45.94 with a total volume of 4.10 million shares traded. Canadian Natural Resources’ shares have advanced 3.07% in the last month and 16.30% in the previous three months. Furthermore, the Company’s stock has gained 22.25% in the past one year. The stock is trading above its 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $44.61 is greater than its 200-day moving average of $43.09. Shares of the Company, which explores for, develops, produces, and markets crude oil, natural gas, and natural gas liquids, are trading at a PE ratio of 20.35. Today’s complimentary report on CNQ.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=CNQ

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors

ReleaseID: 503936

Today’s Free Reports Knight Therapeutics, Acerus Pharma, Nuvo Pharma, and Avivagen

LONDON, UK / ACCESSWIRE / June 28, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the Drug Manufacturers industry: Knight Therapeutics, Acerus Pharmaceuticals, Nuvo Pharmaceuticals, and Avivagen. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index lost 48.84 points, or 0.30%, to close Wednesday’s trading session at 16,231.25. The TSX Venture Exchange shaved off 8.19 points, or 1.10%, to finish at 736.90.

Moreover, the Healthcare index was down by 4.66%, closing at 97.41.

Today’s stocks of interest consist of: Knight Therapeutics Inc. (TSX: GUD), Acerus Pharmaceuticals Corporation (TSX: ASP), Nuvo Pharmaceuticals Inc. (TSX: NRI), and Avivagen Inc. (TSXV: VIV). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Knight Therapeutics Inc.

On Wednesday, shares in Montreal, Canada headquartered Knight Therapeutics Inc. recorded a trading volume of 191,348 shares, which was above their three months average volume of 132,804 shares. The stock ended the day 0.63% higher at $8.00. Knight Therapeutics’ stock has advanced 3.23% in the past three months. The Company’s shares are trading above its 200-day moving average. The stock’s 50-day moving average of $8.04 is above its 200-day moving average of $7.90. Shares of Knight Therapeutics, which operates as a specialty pharmaceutical company in Canada and internationally, are trading at a PE ratio of 63.49. View the research report on GUD.TO at:

www.active-investors.com/registration-sg/?symbol=GUD

Acerus Pharmaceuticals Corp.

On Wednesday, shares in Mississauga, Canada headquartered Acerus Pharmaceuticals Corp. ended the session 2.00% higher at $0.26 with a total volume of 421,500 shares traded. Acerus Pharma’s shares have rallied 96.15% in the previous year. Shares of the Company, which focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health, are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 50-day moving average of $0.33 is greater than its 200-day moving average of $0.30. Get the free report on ASP.TO at:

www.active-investors.com/registration-sg/?symbol=ASP

Nuvo Pharmaceuticals Inc.

Mississauga, Canada headquartered Nuvo Pharmaceuticals Inc.’s stock closed the day 2.94% lower at $2.64. The stock recorded a trading volume of 2,400 shares. Shares of the Company, which produces and sells pharmaceutical products in the US, Canada, and Europe, are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $3.32 is greater than its 50-day moving average of $2.80. Access the most recent report coverage on NRI.TO at:

www.active-investors.com/registration-sg/?symbol=NRI

Avivagen Inc.

Ottawa, Canada headquartered Avivagen Inc.’s stock finish Wednesday’s session 1.49% lower at $0.66 with a total volume of 20,158 shares traded. Avivagen’s shares have advanced 3.13% in the past month. Shares of the Company, which develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal’s own health defenses, are trading below its 200-day moving average. Avivagen’s 200-day moving average of $0.83 is above its 50-day moving average of $0.66. Today’s complimentary report on VIV.V can be accessed at:

www.active-investors.com/registration-sg/?symbol=VIV

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors

ReleaseID: 503938

Free Post Earnings Research Report: Donaldson’s Quarterly Earnings Advanced 17.78%

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want access to our free earnings report on Donaldson Co., Inc. (NYSE: DCI), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=DCI. The Company reported its financial results on May 31, 2018, for the third quarter of the fiscal year 2018, ended April 30, 2018. The Company surpassed analysts’ estimates for earnings and revenues in Q3 FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Donaldson most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=DCI

Earnings Highlights and Summary

For Q3 FY18, Donaldson’s net sales reached $700 million, reflecting an increase of 15.09% from $608.20 million in Q3 FY17. The Company’s revenue numbers exceeded analysts’ consensus estimates of $684.4 million. The increase in revenue includes benefits from currency translation and acquisitions completed in the prior year of approximately 5.7% and 1.4%, respectively.

During Q3 FY18, Donaldson’s cost of sales was $460.40 million, 16.06% higher than $396.70 million in Q3 FY17. The Company’s gross profit advanced 13.29% to $239.60 million in the quarter under review from $211.50 million in the year ago same quarter.

Donaldson incurred operating expenses of $138.70 million in Q3 FY18, an increase of 12.76% from $123 million in Q3 FY17. The Company’s operating income advanced 14.01% to $100.90 million in the reported quarter from $88.50 million in the previous year’s comparable quarter.

Donaldson had net earnings of $69.90 million in the quarter ended April 30, 2018, 16.31% higher than $60.10 million in the corresponding period of last year. The Company’s diluted earnings per share (EPS) also advanced 17.78% to $0.53 in the reported quarter from $0.45 in the year ago same quarter. This was higher than analysts’ consensus estimates of $0.52 per share.

Segment Details

During Q3 FY18, Donaldson’s Engine Products segment reported revenues of $472.30 million, up 16.44% on a y-o-y basis. For the quarter under review, the segment’s off-road net sales advanced 30.48% to $89.90 million on a y-o-y basis; its on-road sales increased 46.53% to $42.20 million on a y-o-y basis; and its aftermarket sales jumped 12.62% to $315.10 million on a y-o-y basis. The segment had earnings before income taxes of $67.80 million in Q3 FY18, 7.45% higher than $63.10 million in Q3 FY17.

For Q3 FY18, Donaldson’s Industrial Products segment’s net revenues ascended 12.39% to $227.70 million on a y-o-y basis. For the reported quarter, the segment’s industrial filtration solutions sales jumped 17.71% to $152.20 million on a y-o-y basis; its gas turbine systems sales increased 2.88% to $32.10 million on a y-o-y basis; while its special applications sales advanced 3.09% to $43.40 million on a y-o-y basis. The segment had earnings before income taxes of $34.80 million in the quarter under review compared to $31.90 million in the year ago corresponding quarter, reflecting an increase of 9.09%.

Cash Matters

Donaldson had cash and cash equivalents of $317.30 million as on April 30, 2018, an increase of 2.89% from $308.40 million as on July 31, 2017. The Company had a long-term debt of $687.50 million as on April 30, 2018, up 27.95% from $537.30 million as on July 31, 2017.

For the nine months ended April 30, 2018, Donaldson’s cash flow from operating activities was $158.70 million, reflecting a decrease of 31.24% from $230.80 million in the comparable period of last year. The Company had a free cash flow of $85.60 million in 9M FY18 compared to $189.60 million in 9M FY17.

Donaldson paid dividends of $70.20 million in the reported period, 1.01% higher than $69.50 million in the prior year’s same period. The Company’s net expenditure on property, plant, and equipment was $73.10 million in 9M FY18, 77.43% higher than $41.20 million in 9M FY17.

Outlook

For the full fiscal year 2018, Donaldson expects adjusted EPS to be between $1.97 and $2.01, reflecting an increase of 2 cents when comparing the midpoints of the current and prior guidance ranges. The Company expects sales to increase by about 18% for FY18 compared to prior forecasts of 13% to 15%. The forecasts includes benefits from currency translation and acquisitions completed in FY17 of approximately 3% and 1%, respectively.

On May 23, 2018, Donaldson’s Board of Directors declared a regular cash dividend of $0.19 per share, an increase of 5.6% from the prior quarterly cash dividend of $0.18 per share. The dividend is payable on June 28, 2018, to shareholders of record as on June 11, 2018. The Company has paid a cash dividend every quarter for 62 years, and has increased the dividend annually for more than 20 years.

Stock Performance Snapshot

June 27, 2018 – At Wednesday’s closing bell, Donaldson’s stock was marginally down 0.59%, ending the trading session at $45.25.

Volume traded for the day: 410.64 thousand shares.

Stock performance in the previous three-month period – up 3.52%; and past twelve-month period – up 0.78%

After yesterday’s close, Donaldson’s market cap was at $6.01 billion.

Price to Earnings (P/E) ratio was at 39.45.

The stock has a dividend yield of 1.68%.

The stock is part of the Industrial Goods sector, categorized under the Diversified Machinery industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors

ReleaseID: 503940

Wired News – Energizer Holdings Signs Agreement to Acquire Reed-Union’s Nu Finish Brands

LONDON, UK / ACCESSWIRE / June 28, 2018 / If you want access to our free research report on Energizer Holdings, Inc. (NYSE: ENR) (“Energizer”), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ENR as the Company’s latest news hit the wire. On June 26, 2018, the Company, which is one of the world’s largest manufacturers of primary batteries and portable lighting products, declared that it has entered into an agreement with Reed-Union Corp. to acquire its automotive appearance business, including the Nu Finish Car Polish and Nu Finish Scratch Doctor brands. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Energizer Holdings most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ENR

Reed-Union’s Strong Hold in Domestic and International Markets

Reed-Union was founded in 1929 as a specialty chemical coatings manufacturer in Chicago, Illinois, US. The Company emphasizes on the goal to produce high quality products, and has been a consumer products pioneer and innovator. At present, the Company is in its fourth generation of leadership. Reed-Union’s auto appearance business has a wide distribution across auto retail channels in the US and it also has a good hold on its international markets in Canada and Australia. Nu Finish and Scratch Doctor have emerged as leading products in their categories, led by the combination of product innovation and effective marketing campaigns.

Acquisition In-Line with Energizer’s Growth Strategy

Alan Hoskins, Chief Executive Officer (CEO) at Energizer, expressed his excitement about the combination of its auto appearance business with Reed-Union’s industry leading appearance brands. The addition of Reed-Union’s Nu Finish and Scratch Doctor brands will enhance Energizer’s existing auto appearance portfolio. The strength of these brands will complement Energizer’s Lexol and Eagle One products. This acquisition is consistent with the Company’s strategy of building its auto care business, both organically and through acquisitions.

Reed-Union Looks for Wider Growth Opportunities

Peter Goldman, President of Reed-Union, believes that combining top-selling Nu Finish brand with Energizer’s portfolio of automotive appearance products and global resources will significantly enhance Reed-Union’s ability to grow its well-established brands. The Company looks forward to increasing its market penetration for serving and supporting the next generation of consumers.

Transaction Financing

For the financing of this transaction, Energizer intends to use a combination of existing cash and committed debt facilities.

Financial Advisors

For the purpose of this transaction, the leading consumer investment banking firm, Sawaya Partners, LLC, served as the exclusive financial advisor to Energizer.

Energizer Declares Pricing of $500 Million of Senior Notes and €650 Million of Senior Notes

On June 21, 2018, Energizer announced the pricing of the offerings of $500 million of 6.375% senior notes, due 2026, by its wholly-owned subsidiary, Energizer Gamma Acquisition Inc.; and €650 million of 4.625% senior notes, due 2026, by its indirect wholly-owned subsidiary, Energizer Gamma Acquisition B.V. Both notes are priced at 100% of the principal amount thereof.

Energizer plans to utilize the proceeds from these offerings, along with its borrowings under new credit facilities, to fund the previously-announced acquisition of the global battery and portable lighting business of Spectrum Brands Holding, and to repay the debt outstanding under its existing credit agreement.

Stock Performance Snapshot

June 27, 2018 – At Wednesday’s closing bell, Energizer’s stock declined 1.02%, ending the trading session at $62.11.

Volume traded for the day: 342.72 thousand shares.

Stock performance in the last month – up 2.00%; previous three-month period – up 17.12%; past twelve-month period – up 26.34%; and year-to-date – up 29.45%

After yesterday’s close, Energizer’s market cap was at $3.68 billion.

Price to Earnings (P/E) ratio was at 29.96.

The stock has a dividend yield of 1.87%.

The stock is part of the Consumer Goods sector, categorized under the Personal Products industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

SOURCE: Active-Investors

ReleaseID: 503941

Small UAV Coalition Member Fresh Air Educators Launches DRONEcourse.com

Industry-leading Online Safety Course and Training Resources Now Available to Help Obtain Part 107 – Remote Pilot Certificate

WASHINGTON, DC / ACCESSWIRE / June 28, 2018 / The Small UAV Coalition is pleased to announce that Coalition member Fresh Air Educators has launched an online preparatory safety course for aspiring Part 107 pilots at DRONEcourse.com.

Since the Part 107 regulations have come into effect, there has been a growing demand for knowledge test preparation and resources across the industry as test takers have taken note of the relative difficulty of the in-person knowledge test, most notably for first-time or new unmanned aircraft systems (UAS) operators looking to obtain a drone license.

“We’ve heard from operators of all kinds expressing the need for proper training resources to adequately prepare for the in-person test,” said Michael Drobac, Executive Director, Small UAV Coalition. “Fresh Air Educators has proven that their expertise in online education leads to better outcomes for learners of all types. The launch of this online course will result in UAS operators being better prepared and educated as the industry continues to see rapid expansion in the United States and abroad.”

With the launch of DRONEcourse.com, UAS operators can now access the interactive, industry-leading online study guide provided by Fresh Air Educators.

The safety course is fully narrated, complete with video and animated competency exercises based on e-learning best practices while also covering all required standards and competencies for the in-person Part 107 knowledge test.

Over the past 20 years, Fresh Air Educators has helped train more than 2 million outdoor enthusiasts to boat, hunt and operate off-highway vehicles. “We’ve applied our proven training and certification process for UAV pilots at DRONEcourse.com,” said Greg Gulliver, General Manager, Fresh Air Educators. “Pilots can expect the same high pass rates, test scores and user ratings that our industry partners have come to expect from our courseware.”

The online safety course also offers a Practice Part 107 exam based on real FAA questions used during the in-person knowledge test.

“We share the core belief that our skies should be safe and that properly training our drone operators will ensure that both the pilots understand their capabilities and that consumers have confidence that pilots are certified, trained and properly tested,” added Kerry Moher, V.P. Business Development, Fresh Air Educators.

Safety and accountability across the UAS industry are critical to ensuring safe integration and unleashing the potential for increased and expanded commercial UAS operations. The Small UAV Coalition calls on the federal government to proactively establish education and training requirements for all UAS operators. Specifically, the Coalition supports online education and training programs to make these opportunities more easily accessible.

Media Contact:

Kerry Moher
Phone: 1-877-722-8838 x222
Email: kerry@freshaireducators.com

SOURCE: DRONEcourse.com

ReleaseID: 503894

Elbit Imaging Announces An Evalution Referring To Elbit Medical Technologies

TEL AVIV, ISRAEL / ACCESSWIRE / June 28, 2018 / Elbit Imaging Ltd. (“EI” or the “Company”) (TASE: EMITF) (NASDAQ: EMITF) announced today that Edison Investment Research (Israel) Ltd. published an evaluation of its subsidiary, Elbit Medical Technologies Ltd. (“Elbit Medical”) (the “Evaluation”):

https://maya.tase.co.il/reports/details/1170363/2/0

The Evaluation assessed the value of Elbit Medical to be NIS 407 million (USD 116 million) in accordance with the assumptions detailed in the Evaluation.

The Company makes reference to the exemption clauses at the end of the Evaluation, which includes a provision that the Evaluation does not constitute a recommendation or opinion regarding the purchase or sale of securities.

The Company holds approximately 89% of Elbit Medical’s outstanding share capital (approximately 58% on a fully diluted basis).

About Elbit
Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Medical Industries through our indirect holdings in Insightec Ltd. and Gamida Cell Ltd.; (ii) Plots in India which are designated for sale (and which were initially designated for residential projects); (iii) Plots in Eastern Europe which are designated for sale (and which were initially designated for development of commercial centers).

For Further
Information:

Company Contact

Ron Hadassi
CEO and Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com

SOURCE: Elbit Imaging Ltd.

ReleaseID: 504006

Another Fortune 500 Company Starts Pilot Program for CIM

EDMONTON, AB / ACCESSWIRE / June 28, 2018 / OneSoft Solutions Inc. (the “Company” or “OneSoft”) (TSX-V: OSS, OTCQB: OSSIF) is pleased to announce that its wholly-owned subsidiary, OneBridge Solutions Inc. (“OneBridge”), has engaged with another Fortune 500 energy company (the “Client”) who will be conducting a proof of concept in the use of the Company’s Cognitive Integrity ManagementTM (“CIM”) software-as-a-service (“SaaS”) solution for segments of its transmission pipeline infrastructure (“Pilot Program”).

“It is very exciting to have garnered the interest of a supermajor oil and gas company to participate in our Pilot Program,” stated CTO Brandon Taylor. “We have worked closely with this Client’s and Microsoft’s personnel during the past few months, to demonstrate the high value proposition that our Machine Learning and Data Science solution, and the advantages that shared learning through the use of Cloud computing can provide. We are very pleased that we have now progressed to the Pilot stage, which we believe may ultimately result in this Client adopting CIM to drive predictive analytics for its entire pipeline infrastructure in the future.”

About the Client

The Client is a publicly traded oil and gas company and is one of the six supermajors in the industry, ranking among the world’s largest integrated refiners, marketers of petroleum products and chemical manufacturers. The Client is recognized as a progressive industry leader, focused on innovation and digital transformation of its business, and a user of Microsoft Azure and other cloud platforms.

About the Pilot Program

Pursuant to the terms of the agreement, OneBridge will normalize the Client’s inline inspection (“ILI”) data for segments of its pipeline, ingest the data, classify features per an alias classification model, align features, and calculate anomaly growth rates. CIM provides revolutionary Pattern Detection and Interacting Threats algorithms using data science and our proprietary Machine Learning algorithms, which are designed to detect unknown threats to pipelines over time using Predictive Analytics, as well as advanced business intelligence, graphical presentations, and reporting of the data that operators require to manage their pipeline infrastructure.

The Pilot Program, using a “succeed fast/fail fast” approach, will accommodate a full evaluation of CIM by the Client within weeks. The objective of the program is to allow the Client to utilize CIM as a key component of its integrity management process during a proof of concept period using its own data. The initial revenue associated with this contract is a nominal fixed fee which recovers OneBridge costs associated with the project.

About OneSoft and OneBridge

OneSoft has developed software technology and products that have capability to transition legacy, on-premise licensed software applications to operate on the Microsoft (MSFT) Azure Cloud Platform. Our business strategy is to seek opportunities to incorporate Data Science and Machine Learning, business intelligence and predictive analytics to create cost-efficient, subscription-based software-as-a-service solutions. Visit www.onesoft.ca for more information.

OneSoft’s wholly owned subsidiary, OneBridge Solutions Inc., develops and markets revolutionary new SaaS solutions that use Data Science and Machine Learning to apply predictive analytics to big data, which assist Oil & Gas pipeline operators to predict pipeline failures and thereby save lives, protect the environment, reduce operational costs and address regulatory compliance requirements. Visit www.onebridgesolutions.com for more information.

For more information, please contact

Dwayne Kushniruk, CEO
dkushniruk@onesoft.ca
(780) 437‐4950

Sean Peasgood, Investor Relations
Sean@SophicCapital.com
(647) 494-7710

Forward-looking Statements

This news release contains forward-looking statements relating to the future operations, product creation revenues and profitability of the Company, the Company’s efforts to develop and commercialize the technology with the capabilities and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expects”, “believe”, “will”, “intends”, “plans” and similar expressions. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Such forward-looking information is provided for the purpose of delivering information about management’s current expectations and plans relating to the future. Investors are cautioned that reliance on such information may not be appropriate for other purposes, such as making investment decisions.

In respect of the forward-looking information and statements, the Company has placed reliance on certain assumptions that it believes are reasonable at this time, including expectations and assumptions concerning, among other things: interest and foreign exchange rates; planned synergies, capital efficiencies and cost-savings; applicable tax laws; the sufficiency of budgeted capital expenditures in carrying out planned activities; the availability and cost of labour and services; the efficacy of its software, its ability to complete projects to expected deadlines, the success of growth projects; future operating costs; that counterparties to material agreements will continue to perform in a timely manner; that there are no unforeseen events preventing the performance of contracts; and that there are no unforeseen material development or other costs related to current growth projects or current operations. Accordingly, readers should not place undue reliance on the forward-looking information contained in this press release. Since forward-looking information addresses future events and conditions, such information by its very nature involves inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to many factors and risks. These include but are not limited to the risks associated with the industries in which the Company operates in general such as: costs and expenses; interest rate and exchange rate fluctuations; competition; human capital engagement and availability, ability to access sufficient financial capital from internal and external sources; and changes in legislation, including but not limited to tax laws.

Readers are cautioned that the foregoing list of factors is not exhaustive. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities within the United States. The securities to be offered have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of such Act or other laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE:OneSoft Solutions Inc.

ReleaseID: 503977

Global Ceramic Matrix Composites Market Supply, Sales, Revenue and Forecast from 2018 to 2025

Global Ceramic Matrix Composites Market Research Report 2018 contains historic data that spans 2013 to 2017, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Industry

Pune, India – June 28, 2018 /MarketersMedia/

Global Ceramic Matrix Composites Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Ceramic Matrix Composites. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Ceramic Matrix Composites market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Ceramic Matrix Composites Market is headed.

Access complete report at: https://www.themarketreports.com/report/global-ceramic-matrix-composites-market-research-report-2018

With this Ceramic Matrix Composites Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are 3M Company, Applied Thin Films, CeramTec International, COI Ceramics, CoorsTek, General Electric Company, Kyocera Corporation, Lancer Systems LP, SGL Carbon Company, Starfire Systems, Ultramet, Ube Industries and others.

Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/827329

When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn’t shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Ceramic Matrix Composites Industry, per application.

All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/827329

List of Chapters:
1 Ceramic Matrix Composites Market Overview
2 Global Ceramic Matrix Composites Market Competitions by Manufacturers
3 Global Ceramic Matrix Composites Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Ceramic Matrix Composites Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Ceramic Matrix Composites Production, Revenue (Value), Price Trend by Type
6 Global Ceramic Matrix Composites Market Analysis by Application
7 Global Ceramic Matrix Composites Manufacturers Profiles/Analysis
8 Ceramic Matrix Composites Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Ceramic Matrix Composites Market Forecast (2018-2025)
13 Research Findings and Conclusion
14 Appendix

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-ceramic-matrix-composites-market-supply-sales-revenue-and-forecast-from-2018-to-2025/368234

For more information, please visit https://www.themarketreports.com/report/global-ceramic-matrix-composites-market-research-report-2018

Source: MarketersMedia

Release ID: 368234

Global Diabetes Therapeutics and Diagnostics Supply (Production), Consumption, Export, Import by Region (2013-2018): Global Market Report

The global Diabetes Therapeutics and Diagnostics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2018 and 2025.

Pune, India – June 28, 2018 /MarketersMedia/

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Diabetes Therapeutics and Diagnostics in these regions, from 2013 to 2025 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Access Report Details at: https://www.themarketreports.com/report/global-diabetes-therapeutics-and-diagnostics-market-research-report-2018

Global Diabetes Therapeutics and Diagnostics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• 77 Elektronika Kft.
• A. Menarini Diagnostics S.R.L
• Abbott Laboratories
• Agamatrix Inc.
• Animas Corp.
• Ascensia
• Becton Dickinson
• Debiotech S.A.
• Eli Lilly And Co.
• Glaxo Smithkline
• Inlight Solutions Inc.
• Johnson & Johnson
• Lifescan Inc.
• Medtronic
• Merck & Co.
• Merck KGAA
• Nipro Corp.
• Novartis Pharma Ag
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Palco Labs Inc.
• Roche
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Terumo Corp.

Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1198906

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Insulin
• Insulin Delivery
• Oral Hypoglycemic Drugs
• Diagnosis And Monitoring
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Diabetes Therapeutics and Diagnostics for each application, including
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Others

Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1198906

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315

Source URL: https://marketersmedia.com/global-diabetes-therapeutics-and-diagnostics-supply-production-consumption-export-import-by-region-2013-2018-global-market-report/368236

For more information, please visit https://www.themarketreports.com/report/global-diabetes-therapeutics-and-diagnostics-market-research-report-2018

Source: MarketersMedia

Release ID: 368236